Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues

Fig. 1

Differential analysis of quantitative proteomic data generated from matched FFPE tissues collected from HGSOC patients (n = 20), post versus pre-neoadjuvant chemotherapy (NACT) treatment. A Volcano plot showing 97 proteins significantly altered between post and pre-NACT treated tissues (LIMMA p < 0.01). B Principal component (PC) analysis of the 97 altered proteins serves explain 34.5% and 8.6% of the variance between these post and pre-NACT treated tumors

Back to article page

Clinical Proteomics

ISSN: 1559-0275